FDA Inspection
Suresh Anne, M.D.Suresh Anne, M.D. – FDA Inspection, Feb 13, 2026
Record Details
This FDA Inspection record concerns Suresh Anne, M.D., with an inspection on February 13, 2026, issued by the Detroit District Office, covering human drugs.
View Company Profile
ID · 702db3e3-c90d-4154-a9af-af832180260c
Inspection Facts
- Inspection number
- 1302630
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.64(b)Safety Reports - Non-Serious Events
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Suresh Anne, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 19, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Suresh Anne, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.